nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolbutamide—SLC22A6—Hydrochlorothiazide—nephrolithiasis	0.427	1	CbGbCtD
Tolbutamide—KCNJ1—loop of Henle—nephrolithiasis	0.116	0.398	CbGeAlD
Tolbutamide—KCNJ1—collecting duct of renal tubule—nephrolithiasis	0.0659	0.226	CbGeAlD
Tolbutamide—KCNJ1—nephron—nephrolithiasis	0.0293	0.101	CbGeAlD
Tolbutamide—SLC22A6—Organic anion transport—SLC22A12—nephrolithiasis	0.0239	0.0983	CbGpPWpGaD
Tolbutamide—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0111	0.0458	CbGpPWpGaD
Tolbutamide—Probenecid—SLC2A9—nephrolithiasis	0.00971	0.541	CrCbGaD
Tolbutamide—Probenecid—SLC22A12—nephrolithiasis	0.00826	0.46	CrCbGaD
Tolbutamide—CYP2C19—urine—nephrolithiasis	0.00758	0.026	CbGeAlD
Tolbutamide—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC3A1—nephrolithiasis	0.00738	0.0303	CbGpPWpGaD
Tolbutamide—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC3A1—nephrolithiasis	0.00685	0.0281	CbGpPWpGaD
Tolbutamide—KCNJ1—nephron tubule—nephrolithiasis	0.00633	0.0217	CbGeAlD
Tolbutamide—CYP2C9—urine—nephrolithiasis	0.00588	0.0202	CbGeAlD
Tolbutamide—KCNJ1—renal system—nephrolithiasis	0.00576	0.0197	CbGeAlD
Tolbutamide—KCNJ1—kidney—nephrolithiasis	0.00557	0.0191	CbGeAlD
Tolbutamide—KCNJ1—cortex of kidney—nephrolithiasis	0.00542	0.0186	CbGeAlD
Tolbutamide—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A6—nephrolithiasis	0.00475	0.0195	CbGpPWpGaD
Tolbutamide—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC7A9—nephrolithiasis	0.00464	0.019	CbGpPWpGaD
Tolbutamide—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A6—nephrolithiasis	0.00441	0.0181	CbGpPWpGaD
Tolbutamide—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC3A1—nephrolithiasis	0.00435	0.0179	CbGpPWpGaD
Tolbutamide—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A3—nephrolithiasis	0.00435	0.0179	CbGpPWpGaD
Tolbutamide—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC7A9—nephrolithiasis	0.0043	0.0177	CbGpPWpGaD
Tolbutamide—SLC22A6—nephron tubule—nephrolithiasis	0.00406	0.0139	CbGeAlD
Tolbutamide—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC3A1—nephrolithiasis	0.00404	0.0166	CbGpPWpGaD
Tolbutamide—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A3—nephrolithiasis	0.00404	0.0166	CbGpPWpGaD
Tolbutamide—SLC22A6—cortex of kidney—nephrolithiasis	0.00348	0.0119	CbGeAlD
Tolbutamide—SLC15A1—nephron tubule—nephrolithiasis	0.00338	0.0116	CbGeAlD
Tolbutamide—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A1—nephrolithiasis	0.0033	0.0135	CbGpPWpGaD
Tolbutamide—ABCC8—renal system—nephrolithiasis	0.00322	0.011	CbGeAlD
Tolbutamide—ABCC8—kidney—nephrolithiasis	0.00311	0.0107	CbGeAlD
Tolbutamide—SLC15A1—renal system—nephrolithiasis	0.00308	0.0105	CbGeAlD
Tolbutamide—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A1—nephrolithiasis	0.00306	0.0126	CbGpPWpGaD
Tolbutamide—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A1—nephrolithiasis	0.00306	0.0126	CbGpPWpGaD
Tolbutamide—Heartburn—Hydrochlorothiazide—nephrolithiasis	0.00301	0.153	CcSEcCtD
Tolbutamide—SLC15A1—kidney—nephrolithiasis	0.00297	0.0102	CbGeAlD
Tolbutamide—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A1—nephrolithiasis	0.00284	0.0117	CbGpPWpGaD
Tolbutamide—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC7A9—nephrolithiasis	0.00273	0.0112	CbGpPWpGaD
Tolbutamide—ABCC8—Regulation of insulin secretion—CHRM3—nephrolithiasis	0.00259	0.0106	CbGpPWpGaD
Tolbutamide—SLCO2B1—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00254	0.0104	CbGpPWpGaD
Tolbutamide—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC7A9—nephrolithiasis	0.00253	0.0104	CbGpPWpGaD
Tolbutamide—SLCO2B1—renal system—nephrolithiasis	0.00252	0.00864	CbGeAlD
Tolbutamide—KCNJ11—Regulation of insulin secretion—CHRM3—nephrolithiasis	0.00251	0.0103	CbGpPWpGaD
Tolbutamide—SLCO2B1—kidney—nephrolithiasis	0.00243	0.00835	CbGeAlD
Tolbutamide—Jaundice cholestatic—Hydrochlorothiazide—nephrolithiasis	0.00236	0.12	CcSEcCtD
Tolbutamide—SLCO2B1—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00232	0.00953	CbGpPWpGaD
Tolbutamide—SLCO2B1—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00232	0.00953	CbGpPWpGaD
Tolbutamide—SLCO1A2—renal system—nephrolithiasis	0.00232	0.00795	CbGeAlD
Tolbutamide—SLCO1A2—kidney—nephrolithiasis	0.00224	0.00768	CbGeAlD
Tolbutamide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00223	0.00917	CbGpPWpGaD
Tolbutamide—SLC15A2—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00212	0.00872	CbGpPWpGaD
Tolbutamide—SLC15A2—nephron tubule—nephrolithiasis	0.00211	0.00725	CbGeAlD
Tolbutamide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00208	0.00852	CbGpPWpGaD
Tolbutamide—ABCC8—Integration of energy metabolism—CHRM3—nephrolithiasis	0.00204	0.00837	CbGpPWpGaD
Tolbutamide—KCNJ11—Integration of energy metabolism—CHRM3—nephrolithiasis	0.00198	0.00812	CbGpPWpGaD
Tolbutamide—SLC15A1—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00197	0.0081	CbGpPWpGaD
Tolbutamide—Aplastic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00194	0.0991	CcSEcCtD
Tolbutamide—SLC15A2—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00194	0.00798	CbGpPWpGaD
Tolbutamide—SLC15A2—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00194	0.00798	CbGpPWpGaD
Tolbutamide—SLC15A2—renal system—nephrolithiasis	0.00192	0.00659	CbGeAlD
Tolbutamide—SLC15A2—kidney—nephrolithiasis	0.00186	0.00638	CbGeAlD
Tolbutamide—SLC15A2—cortex of kidney—nephrolithiasis	0.00181	0.00621	CbGeAlD
Tolbutamide—SLC15A1—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.0018	0.0074	CbGpPWpGaD
Tolbutamide—SLC15A1—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.0018	0.0074	CbGpPWpGaD
Tolbutamide—SLCO2B1—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00176	0.00722	CbGpPWpGaD
Tolbutamide—SLCO2B1—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00176	0.00722	CbGpPWpGaD
Tolbutamide—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00166	0.0848	CcSEcCtD
Tolbutamide—CYP2C18—Biological oxidations—SLC26A1—nephrolithiasis	0.00165	0.00677	CbGpPWpGaD
Tolbutamide—SLCO2B1—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00164	0.00672	CbGpPWpGaD
Tolbutamide—SLCO2B1—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00164	0.00672	CbGpPWpGaD
Tolbutamide—CYP2C8—renal system—nephrolithiasis	0.00162	0.00555	CbGeAlD
Tolbutamide—CYP2C8—kidney—nephrolithiasis	0.00156	0.00537	CbGeAlD
Tolbutamide—SLCO1A2—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00156	0.00639	CbGpPWpGaD
Tolbutamide—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.00151	0.0769	CcSEcCtD
Tolbutamide—SLC15A2—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00147	0.00605	CbGpPWpGaD
Tolbutamide—SLC15A2—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00147	0.00605	CbGpPWpGaD
Tolbutamide—SLC22A6—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00146	0.00601	CbGpPWpGaD
Tolbutamide—SLCO2B1—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00146	0.00599	CbGpPWpGaD
Tolbutamide—SLCO2B1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00145	0.00594	CbGpPWpGaD
Tolbutamide—SLCO2B1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00145	0.00594	CbGpPWpGaD
Tolbutamide—SLCO1A2—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00142	0.00585	CbGpPWpGaD
Tolbutamide—SLCO1A2—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00142	0.00585	CbGpPWpGaD
Tolbutamide—SLC15A2—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00137	0.00562	CbGpPWpGaD
Tolbutamide—SLC15A2—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00137	0.00562	CbGpPWpGaD
Tolbutamide—SLC15A1—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00137	0.00561	CbGpPWpGaD
Tolbutamide—SLC15A1—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00137	0.00561	CbGpPWpGaD
Tolbutamide—ABCC8—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00135	0.00552	CbGpPWpGaD
Tolbutamide—ABCC8—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00135	0.00552	CbGpPWpGaD
Tolbutamide—SLC22A6—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00134	0.0055	CbGpPWpGaD
Tolbutamide—SLC22A6—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00134	0.0055	CbGpPWpGaD
Tolbutamide—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.00131	0.0666	CcSEcCtD
Tolbutamide—SLCO2B1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00129	0.0053	CbGpPWpGaD
Tolbutamide—SLC15A1—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00127	0.00522	CbGpPWpGaD
Tolbutamide—SLC15A1—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00127	0.00522	CbGpPWpGaD
Tolbutamide—SLC15A2—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00122	0.00501	CbGpPWpGaD
Tolbutamide—SLC15A2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00121	0.00497	CbGpPWpGaD
Tolbutamide—SLC15A2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00121	0.00497	CbGpPWpGaD
Tolbutamide—ABCC8—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.0012	0.00492	CbGpPWpGaD
Tolbutamide—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00119	0.0604	CcSEcCtD
Tolbutamide—SLCO2B1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00118	0.00484	CbGpPWpGaD
Tolbutamide—SLCO2B1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00118	0.00484	CbGpPWpGaD
Tolbutamide—SLC15A1—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00113	0.00465	CbGpPWpGaD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00112	0.00462	CbGpPWpGaD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00112	0.00462	CbGpPWpGaD
Tolbutamide—ABCC8—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.0011	0.0045	CbGpPWpGaD
Tolbutamide—ABCC8—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.0011	0.0045	CbGpPWpGaD
Tolbutamide—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00108	0.0551	CcSEcCtD
Tolbutamide—SLC15A2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00108	0.00443	CbGpPWpGaD
Tolbutamide—SLCO1A2—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00108	0.00443	CbGpPWpGaD
Tolbutamide—SLCO1A2—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00108	0.00443	CbGpPWpGaD
Tolbutamide—SLC22A6—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00101	0.00417	CbGpPWpGaD
Tolbutamide—SLC22A6—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00101	0.00417	CbGpPWpGaD
Tolbutamide—SLCO1A2—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.001	0.00412	CbGpPWpGaD
Tolbutamide—SLCO1A2—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.001	0.00412	CbGpPWpGaD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.001	0.00411	CbGpPWpGaD
Tolbutamide—SLC15A2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000987	0.00405	CbGpPWpGaD
Tolbutamide—SLC15A2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000987	0.00405	CbGpPWpGaD
Tolbutamide—SLC22A6—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.000943	0.00387	CbGpPWpGaD
Tolbutamide—SLC22A6—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.000943	0.00387	CbGpPWpGaD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000916	0.00376	CbGpPWpGaD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000916	0.00376	CbGpPWpGaD
Tolbutamide—Erythema—Hydrochlorothiazide—nephrolithiasis	0.000905	0.0461	CcSEcCtD
Tolbutamide—SLCO1A2—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.000894	0.00367	CbGpPWpGaD
Tolbutamide—SLCO2B1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000894	0.00367	CbGpPWpGaD
Tolbutamide—SLCO2B1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000894	0.00367	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000888	0.00365	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000888	0.00365	CbGpPWpGaD
Tolbutamide—SLC22A6—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.000841	0.00345	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000834	0.00343	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000834	0.00343	CbGpPWpGaD
Tolbutamide—SLCO2B1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000831	0.00341	CbGpPWpGaD
Tolbutamide—ABCC8—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000831	0.00341	CbGpPWpGaD
Tolbutamide—ABCC8—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000831	0.00341	CbGpPWpGaD
Tolbutamide—SLCO2B1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000831	0.00341	CbGpPWpGaD
Tolbutamide—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00081	0.0413	CcSEcCtD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000791	0.00325	CbGpPWpGaD
Tolbutamide—ABCC8—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000773	0.00317	CbGpPWpGaD
Tolbutamide—ABCC8—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000773	0.00317	CbGpPWpGaD
Tolbutamide—SLC15A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000748	0.00307	CbGpPWpGaD
Tolbutamide—SLC15A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000748	0.00307	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000744	0.00305	CbGpPWpGaD
Tolbutamide—SLCO2B1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000741	0.00304	CbGpPWpGaD
Tolbutamide—SLCO2B1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000741	0.00304	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000724	0.00297	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000724	0.00297	CbGpPWpGaD
Tolbutamide—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.000723	0.0369	CcSEcCtD
Tolbutamide—SLC15A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000696	0.00286	CbGpPWpGaD
Tolbutamide—SLC15A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000696	0.00286	CbGpPWpGaD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000694	0.00285	CbGpPWpGaD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000694	0.00285	CbGpPWpGaD
Tolbutamide—ABCC8—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000689	0.00283	CbGpPWpGaD
Tolbutamide—ABCC8—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000689	0.00283	CbGpPWpGaD
Tolbutamide—CYP2C8—Biological oxidations—SLC26A1—nephrolithiasis	0.000686	0.00282	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00068	0.00279	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00068	0.00279	CbGpPWpGaD
Tolbutamide—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00065	0.0331	CcSEcCtD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000646	0.00265	CbGpPWpGaD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000646	0.00265	CbGpPWpGaD
Tolbutamide—SLC15A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00062	0.00255	CbGpPWpGaD
Tolbutamide—SLC15A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00062	0.00255	CbGpPWpGaD
Tolbutamide—CYP2C19—Biological oxidations—SLC26A1—nephrolithiasis	0.000612	0.00251	CbGpPWpGaD
Tolbutamide—SLCO2B1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000592	0.00243	CbGpPWpGaD
Tolbutamide—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.000587	0.0299	CcSEcCtD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000575	0.00236	CbGpPWpGaD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000575	0.00236	CbGpPWpGaD
Tolbutamide—CYP2C9—Biological oxidations—SLC26A1—nephrolithiasis	0.000558	0.00229	CbGpPWpGaD
Tolbutamide—ABCC8—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000551	0.00226	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000548	0.00225	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000548	0.00225	CbGpPWpGaD
Tolbutamide—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.000522	0.0266	CcSEcCtD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000516	0.00212	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000516	0.00212	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00051	0.00209	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00051	0.00209	CbGpPWpGaD
Tolbutamide—SLC15A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000496	0.00204	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000479	0.00197	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000479	0.00197	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—GRHPR—nephrolithiasis	0.000477	0.00196	CbGpPWpGaD
Tolbutamide—Rash—Hydrochlorothiazide—nephrolithiasis	0.000466	0.0237	CcSEcCtD
Tolbutamide—KCNJ11—Metabolism—GRHPR—nephrolithiasis	0.000463	0.0019	CbGpPWpGaD
Tolbutamide—Headache—Hydrochlorothiazide—nephrolithiasis	0.000463	0.0236	CcSEcCtD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00046	0.00189	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000454	0.00187	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000454	0.00187	CbGpPWpGaD
Tolbutamide—Nausea—Hydrochlorothiazide—nephrolithiasis	0.000439	0.0224	CcSEcCtD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000427	0.00175	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000427	0.00175	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—AGXT—nephrolithiasis	0.000426	0.00175	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—AGXT—nephrolithiasis	0.000413	0.00169	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—GRHPR—nephrolithiasis	0.000372	0.00153	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000363	0.00149	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—SLC26A1—nephrolithiasis	0.000362	0.00149	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—APRT—nephrolithiasis	0.000362	0.00149	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—SLC26A1—nephrolithiasis	0.000351	0.00144	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—APRT—nephrolithiasis	0.000351	0.00144	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000341	0.0014	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—AGXT—nephrolithiasis	0.000332	0.00136	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—GRHPR—nephrolithiasis	0.000315	0.00129	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—SLC26A1—nephrolithiasis	0.000282	0.00116	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—APRT—nephrolithiasis	0.000282	0.00116	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—AGXT—nephrolithiasis	0.000281	0.00115	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—AQP1—nephrolithiasis	0.000258	0.00106	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—AQP1—nephrolithiasis	0.00025	0.00103	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—SLC26A1—nephrolithiasis	0.000239	0.000981	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—APRT—nephrolithiasis	0.000239	0.000981	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—CHRM3—nephrolithiasis	0.000233	0.000958	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—CHRM3—nephrolithiasis	0.000226	0.000928	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—AQP1—nephrolithiasis	0.000201	0.000825	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—CHRM3—nephrolithiasis	0.000182	0.000746	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—AQP1—nephrolithiasis	0.00017	0.000699	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—GRHPR—nephrolithiasis	0.000155	0.000636	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—CHRM3—nephrolithiasis	0.000154	0.000632	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GRHPR—nephrolithiasis	0.000138	0.000567	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—AGXT—nephrolithiasis	0.000138	0.000567	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GRHPR—nephrolithiasis	0.000126	0.000517	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—AGXT—nephrolithiasis	0.000123	0.000506	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—SLC26A1—nephrolithiasis	0.000117	0.000482	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—APRT—nephrolithiasis	0.000117	0.000482	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—AGXT—nephrolithiasis	0.000112	0.000461	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—SLC26A1—nephrolithiasis	0.000105	0.00043	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—APRT—nephrolithiasis	0.000105	0.00043	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—SLC26A1—nephrolithiasis	9.55e-05	0.000392	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—APRT—nephrolithiasis	9.55e-05	0.000392	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—AQP1—nephrolithiasis	8.36e-05	0.000343	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CHRM3—nephrolithiasis	7.56e-05	0.00031	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—AQP1—nephrolithiasis	7.46e-05	0.000306	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—AQP1—nephrolithiasis	6.81e-05	0.000279	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CHRM3—nephrolithiasis	6.75e-05	0.000277	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CHRM3—nephrolithiasis	6.15e-05	0.000253	CbGpPWpGaD
